NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University of British Columbia
Conditions: Covid19, Asymptomatic Shedding Viral
Interventions: SD Biosensor
Countries: Canada
Point-of-care testing can provide an additional layer of protection to reduce transmission of COVID-19 safely and effectively in the population, and if such tests can be self-administered, barriers to access may be reduced. The investigators will conduct a study among those self-identifying as asymptomatic for COVID-19 to evaluate the reliability and feasibility of self-administration of a point-of-care nasal swab test, determine the sensitivity and specificity of the point-of-care nasal swab test relative to reverse transciptase polymerase chain reaction (RT-PCR) testing, and gather quantitative and qualitative data on the acceptability and self efficacy of self-administration.
Sex: ALL
Age: 16 Years to 80 Years
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Inclusion Criteria: * Male or female aged 16 years and over * Living or working at University of British Columbia * Self identified as asymptomatic for COVID-19 * Participants able to give written informed consent Exclusion Criteria: * Anyone who is self identified as having COVID-19 symptoms * Those diagnosed with COVID-19 in last 30 days
- Vancouver, British Columbia, Canada